# Azathioprine in MOGAD

> **NCT05349006** · PHASE3 · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 126 (estimated)

## Conditions studied

- Central Nervous System Inflammation
- MOG-IgG Associated Disease

## Interventions

- **DRUG:** Azathioprine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05349006
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-12
- **Primary completion:** 2026-12-12
- **Final completion:** 2029-12-12
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349006, "Azathioprine in MOGAD". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05349006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*